![POSSIBLE ENDPOINTS IN A PRODROMAL ALZHEIMER'S DISEASE TRIAL • The Journal of Prevention of Alzheimer's Disease POSSIBLE ENDPOINTS IN A PRODROMAL ALZHEIMER'S DISEASE TRIAL • The Journal of Prevention of Alzheimer's Disease](https://www.jpreventionalzheimer.com/wp-content/uploads/2015/02/FIG-1-WESSELS.gif)
POSSIBLE ENDPOINTS IN A PRODROMAL ALZHEIMER'S DISEASE TRIAL • The Journal of Prevention of Alzheimer's Disease
![A COMBINED MEASURE OF COGNITION AND FUNCTION FOR CLINICAL TRIALS: THE INTEGRATED ALZHEIMER'S DISEASE RATING SCALE (IADRS) • The Journal of Prevention of Alzheimer's Disease A COMBINED MEASURE OF COGNITION AND FUNCTION FOR CLINICAL TRIALS: THE INTEGRATED ALZHEIMER'S DISEASE RATING SCALE (IADRS) • The Journal of Prevention of Alzheimer's Disease](https://www.jpreventionalzheimer.com/wp-content/uploads/2015/10/TAB-4-WESSELS2.gif)
A COMBINED MEASURE OF COGNITION AND FUNCTION FOR CLINICAL TRIALS: THE INTEGRATED ALZHEIMER'S DISEASE RATING SCALE (IADRS) • The Journal of Prevention of Alzheimer's Disease
![ROC curves for ADCS-MCI-ADL and ADAS-cog. The optimal cut-points on the... | Download Scientific Diagram ROC curves for ADCS-MCI-ADL and ADAS-cog. The optimal cut-points on the... | Download Scientific Diagram](https://www.researchgate.net/publication/7263648/figure/fig1/AS:601616969392154@1520448071715/ROC-curves-for-ADCS-MCI-ADL-and-ADAS-cog-The-optimal-cut-points-on-the-receiver-operator.png)
ROC curves for ADCS-MCI-ADL and ADAS-cog. The optimal cut-points on the... | Download Scientific Diagram
![Aducanumab Treatment in Clinical Trials Lowered Participants' Levels of Potential Blood Biomarker for Alzheimer Disease - Practical Neurology Aducanumab Treatment in Clinical Trials Lowered Participants' Levels of Potential Blood Biomarker for Alzheimer Disease - Practical Neurology](https://core4.bmctoday.net/storage/images/211112_AducanumabTable2_1636729535.jpg)
Aducanumab Treatment in Clinical Trials Lowered Participants' Levels of Potential Blood Biomarker for Alzheimer Disease - Practical Neurology
![A COMBINED MEASURE OF COGNITION AND FUNCTION FOR CLINICAL TRIALS: THE INTEGRATED ALZHEIMER'S DISEASE RATING SCALE (IADRS) • The Journal of Prevention of Alzheimer's Disease A COMBINED MEASURE OF COGNITION AND FUNCTION FOR CLINICAL TRIALS: THE INTEGRATED ALZHEIMER'S DISEASE RATING SCALE (IADRS) • The Journal of Prevention of Alzheimer's Disease](https://www.jpreventionalzheimer.com/wp-content/uploads/2015/10/iADRS.ms_.fig5_.gif)
A COMBINED MEASURE OF COGNITION AND FUNCTION FOR CLINICAL TRIALS: THE INTEGRATED ALZHEIMER'S DISEASE RATING SCALE (IADRS) • The Journal of Prevention of Alzheimer's Disease
![Oral Tau Aggregation Inhibitor for Alzheimer's Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate | The Journal of Oral Tau Aggregation Inhibitor for Alzheimer's Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate | The Journal of](https://media.springernature.com/m685/springer-static/image/art%3A10.14283%2Fjpad.2022.63/MediaObjects/42414_2022_63_Fig3_HTML.jpg)
Oral Tau Aggregation Inhibitor for Alzheimer's Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate | The Journal of
Flow diagram of the study protocol. ADAS-cog12, Alzheimer's Disease... | Download Scientific Diagram
![A COMBINED MEASURE OF COGNITION AND FUNCTION FOR CLINICAL TRIALS: THE INTEGRATED ALZHEIMER'S DISEASE RATING SCALE (IADRS) • The Journal of Prevention of Alzheimer's Disease A COMBINED MEASURE OF COGNITION AND FUNCTION FOR CLINICAL TRIALS: THE INTEGRATED ALZHEIMER'S DISEASE RATING SCALE (IADRS) • The Journal of Prevention of Alzheimer's Disease](https://www.jpreventionalzheimer.com/wp-content/uploads/2015/10/iADRS.ms_.fig6_.gif)
A COMBINED MEASURE OF COGNITION AND FUNCTION FOR CLINICAL TRIALS: THE INTEGRATED ALZHEIMER'S DISEASE RATING SCALE (IADRS) • The Journal of Prevention of Alzheimer's Disease
![Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet | Neurology Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet | Neurology](https://www.neurology.org/cms/10.1212/WNL.0000000000207663/asset/68a467fa-3097-44f5-827d-2f6434f6c682/assets/images/large/wnl.0000000000207663f2.jpg)
Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet | Neurology
![Activities of daily living in dementia: revalidation of the E-ADL test and suggestions for further development | BMC Psychiatry | Full Text Activities of daily living in dementia: revalidation of the E-ADL test and suggestions for further development | BMC Psychiatry | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2F1471-244X-12-208/MediaObjects/12888_2012_Article_1258_Fig2_HTML.jpg)
Activities of daily living in dementia: revalidation of the E-ADL test and suggestions for further development | BMC Psychiatry | Full Text
![Nutrients | Free Full-Text | Efficacy of Probiotic Supplements on Brain-Derived Neurotrophic Factor, Inflammatory Biomarkers, Oxidative Stress and Cognitive Function in Patients with Alzheimer’s Dementia: A 12-Week Randomized, Double-Blind Active ... Nutrients | Free Full-Text | Efficacy of Probiotic Supplements on Brain-Derived Neurotrophic Factor, Inflammatory Biomarkers, Oxidative Stress and Cognitive Function in Patients with Alzheimer’s Dementia: A 12-Week Randomized, Double-Blind Active ...](https://www.mdpi.com/nutrients/nutrients-16-00016/article_deploy/html/images/nutrients-16-00016-g004.png)
Nutrients | Free Full-Text | Efficacy of Probiotic Supplements on Brain-Derived Neurotrophic Factor, Inflammatory Biomarkers, Oxidative Stress and Cognitive Function in Patients with Alzheimer’s Dementia: A 12-Week Randomized, Double-Blind Active ...
![Estimated mean change from baseline over time on ADAS-cog 11, CDR-sb... | Download Scientific Diagram Estimated mean change from baseline over time on ADAS-cog 11, CDR-sb... | Download Scientific Diagram](https://www.researchgate.net/publication/259723645/figure/fig2/AS:213388891299847@1427887284196/Estimated-mean-change-from-baseline-over-time-on-ADAS-cog-11-CDR-sb-and-ADCS-ADL-for.png)
Estimated mean change from baseline over time on ADAS-cog 11, CDR-sb... | Download Scientific Diagram
![Change in the MMSE, ADAS-cog, NPI, ADSC-ADL, and CDR-SB scores from... | Download Scientific Diagram Change in the MMSE, ADAS-cog, NPI, ADSC-ADL, and CDR-SB scores from... | Download Scientific Diagram](https://www.researchgate.net/profile/Ben-Chen-22/publication/344149082/figure/fig6/AS:935627663081473@1600082426518/Change-in-the-MMSE-ADAS-cog-NPI-ADSC-ADL-and-CDR-SB-scores-from-baseline-in-the.png)
Change in the MMSE, ADAS-cog, NPI, ADSC-ADL, and CDR-SB scores from... | Download Scientific Diagram
![Predictors of Sustained Response to Rivastigmine in Patients With Alzheimer's Disease: A Retrospective Analysis | Psychiatrist.com Predictors of Sustained Response to Rivastigmine in Patients With Alzheimer's Disease: A Retrospective Analysis | Psychiatrist.com](https://www.psychiatrist.com/PublishingImages/10m01101t2.gif)
Predictors of Sustained Response to Rivastigmine in Patients With Alzheimer's Disease: A Retrospective Analysis | Psychiatrist.com
![LS mean change from baseline in (A) ADAS-Cog11, (B) ADAS-Cog14, (C)... | Download Scientific Diagram LS mean change from baseline in (A) ADAS-Cog11, (B) ADAS-Cog14, (C)... | Download Scientific Diagram](https://www.researchgate.net/publication/280694389/figure/fig1/AS:267429055078420@1440771463132/LS-mean-change-from-baseline-in-A-ADAS-Cog11-B-ADAS-Cog14-C-MMSE-D-ADCS-ADL.png)